Research ArticleOriginal Article
Open Access

Serotonin and serotonin transporter levels in autistic children

Haidar A. Abdulamir, Omar F. Abdul-Rasheed and Emad A. Abdulghani
Saudi Medical Journal May 2018, 39 (5) 487-494; DOI: https://doi.org/10.15537/smj.2018.5.21751

References

  1. ↵
    1. Abdulamir HA,
    2. Abdul-Rasheed OF,
    3. Abdulghani EA
    (2016) Low oxytocin and melatonin levels and their possible role in the diagnosis and prognosis in Iraqi autistic children. Saudi Med J 37:29–36.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Zafeiriou D,
    2. Ververi A,
    3. Vargiami E
    (2009) The serotonergic system: its role in pathogenesis and early developmental treatment of autism. Curr Neuropharmacol 7:150–157.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Rose'Meyer R
    (2013) A review of the serotonin transporter and prenatal cortisol in the development of autism spectrum disorders. Mol Autism 4:37.
    OpenUrl
  4. ↵
    1. Halladay AK,
    2. Bishop S,
    3. Constantino JN,
    4. Daniels AM,
    5. Koenig K,
    6. Palmer K,
    7. et al.
    (2015) Sex and gender differences in autism spectrum disorder: summarizing evidence gaps and identifying emerging areas of priority. Mol Autism 6:36.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Quaak I,
    2. Brouns MR,
    3. Van de Bor M
    (2013) The dynamics of autism spectrum disorders: how neurotoxic compounds and neurotransmitters interact. Int J Environ Res Public Health 10:3384–3408.
    OpenUrl
  6. ↵
    1. Arya A,
    2. Sindhwani G
    (2016) Autism. An early-onset neurodevelopmental disorder. International Journal of Pharmaceutical Sciences and Research 7:3567–3575.
    OpenUrl
  7. ↵
    1. Carla AM,
    2. Herrington J,
    3. Siegel M,
    4. Scarpa A,
    5. Brenna BM,
    6. Scahill L,
    7. Susan WW
    (2013) The role of emotion regulation in autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 52:679–688.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Celada P,
    2. Puig MV,
    3. Artigas F
    (2013) Serotonin modulation of cortical neurons and networks. Front Integr Neurosci 7:25.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Adamsen D,
    2. Ramaekers V,
    3. Ho HTB,
    4. Britschgi C,
    5. Rüfenacht V,
    6. Meili D,
    7. et al.
    (2014) Autism spectrum disorder associated with low serotonin in CSF and mutations in the SLC29A4 plasma membrane monoamine transporter (PMAT) gene. Molecular Autism 43:2–11.
    OpenUrl
  10. ↵
    1. Ecker C,
    2. Bookheimer SY,
    3. Murphy DG
    (2015) Neuroimaging in autism spectrum disorder: brain structure and function across the lifespan. Lancet Neurol 14:1121–1134.
    OpenUrlCrossRefPubMed
    1. Berg AT,
    2. Dobyns WB
    (2015) Progress in autism and related disorders of brain development. Lancet Neurol 14:1069–1070.
    OpenUrl
  12. ↵
    1. Hamilton PJ,
    2. Campbell NG,
    3. Sharma S
    (2013) De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder. Mol Psychiatry 18:1315–1323.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Jenkins TA,
    2. Nguyen JC,
    3. Polglaze KE,
    4. Bertrand PP
    (2016) Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis. Nutrients 8:E56.
    OpenUrl
  14. ↵
    1. Meyer RR
    (2013) A review of the serotonin transporter and prenatal cortisol in the development of autism spectrum disorders. Molecular Autism 37:2–16.
    OpenUrl
  15. ↵
    1. Meneses A
    (2013) 5-HT systems: emergent targets for memory formation and memory alterations. Rev Neurosci 24:629–664.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Gabriele S,
    2. Sacco R,
    3. Persico AM
    (2014) Blood serotonin levels in autism spectrum disorder: a systematic review and meta-analysis. Eur Neuropsychopharmacol 24:919–929.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Muller CL,
    2. Anacker AMJ,
    3. Veenstra-VanderWeele J
    (2016) The serotonin system in autism spectrum disorder: From biomarker to animal models. Neuroscience 321:24–41.
    OpenUrlCrossRef
  18. ↵
    1. Ruggeri B,
    2. Sarkans U,
    3. Schumann G,
    4. Persico AM
    (2014) Biomarkers in autism spectrum disorder: the old and the new. Psychopharmacology 231:1201–1216.
    OpenUrl
  19. ↵
    1. Meguid NA,
    2. Gebril OH,
    3. Khalil RO
    (2015) A study of blood serotonin and serotonin transporter promoter variant (5-HTTLPR) polymorphism in Egyptian autistic children. Adv Biomed Res 4:94.
    OpenUrl
    1. Siemann JK,
    2. Muller CL,
    3. Forsberg CG,
    4. Veenstra-VanderWeele J,
    5. Wallace MT
    (2017) An autism-associated serotonin transporter variant disrupts multisensory processing. Transl Psychiatry 7:e1067.
    OpenUrl
  21. ↵
    1. Yang CJ,
    2. Tan HP,
    3. Du YJ
    (2014) The developmental disruptions of serotonin signaling may be involved in autism during early brain development. Neuroscience 267:1–10.
    OpenUrl
  22. ↵
    1. Alabdali A,
    2. Al-Ayadhi L,
    3. El-Ansary A
    (2014) Association of social and cognitive impairment and biomarkers in autism spectrum disorders. J Neuroinflammation 11:4.
    OpenUrl
    1. American Psychiatric Association
    (2013) Diagnostic and statistical manual of mental disorders (American Psychiatric Association, Washington (DC)), 5th ed.
  24. ↵
    1. Hajian-Tilaki K
    (2013) Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J Intern Med 4:627–635.
    OpenUrlPubMed
  25. ↵
    1. Veenstra-VanderWeele J,
    2. Muller CL,
    3. Iwamoto H,
    4. Sauer JE,
    5. Owens WA,
    6. Shah CR,
    7. et al.
    (2012) Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc Natl Acad Sci USA 109:5469–5474.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Bijl N,
    2. Thys C,
    3. Wittevrongel C,
    4. De la Marche W,
    5. Devriendt K,
    6. Peeters H,
    7. et al.
    (2015) Platelet studies in autism spectrum disorder patients and first-degree relatives. Mol Autism 6:57.
    OpenUrl
  27. ↵
    1. Anderson GM,
    2. Cook EH Jr.
    (2016) Commentary on “Platelet Studies in Autism Spectrum Disorder Patients and First-Degree Relatives” Mol Autism 7:20.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Dayem H,
    2. Bordeny M,
    3. Ragheb D
    (2018) Study of serum level of serotonin in children with autism spectrum disorder. EC Paediatrics 7:11–18.
    OpenUrl
  29. ↵
    1. Yang CJ,
    2. Liu CL,
    3. Sang B,
    4. Zhu XM,
    5. Du YJ
    (2015) The combined role of serotonin and interleukin-6 as biomarker for autism. Neuroscience 284:290–296.
    OpenUrl
  30. ↵
    1. Tordjman S,
    2. Anderson GM,
    3. Cohen D,
    4. Kermarrec S,
    5. Carlier M,
    6. Touitou Y,
    7. et al.
    (2013) Presence of autism, hyperserotonemia, and severe expressive language impairment in Williams-Beuren syndrome. Mol Autism 4:29.
    OpenUrl
  31. ↵
    1. Hranilovic D,
    2. Bujas-Petkovic Z,
    3. Vragovic R,
    4. Vuk T,
    5. Hock K,
    6. Jernej B
    (2007) Hyperserotonemia in adults with autistic disorder. J Autism Dev Disord 37:1934–1940.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Hsiao EY
    (2014) Gastrointestinal issues in autism spectrum disorder. Harv Rev Psychiatry 22:104–111.
    OpenUrlCrossRef
  33. ↵
    1. Yubero-Lahoz S,
    2. Robledo P,
    3. Farré M,
    4. de la Torre R
    (2013) Platelet SERT as a peripheral biomarker of serotonergic neurotransmission in the central nervous system. Curr Med Chem 20:1382–1396.
    OpenUrl
  34. ↵
    1. Iwata K,
    2. Matsuzaki H,
    3. Tachibana T,
    4. Ohno K,
    5. Yoshimura S,
    6. Takamura H,
    7. et al.
    (2014) N-ethylmaleimide-sensitive factor interacts with the serotonin transporter and modulates its trafficking: implications for pathophysiology in autism. Mol Autism 5:33.
    OpenUrl
  35. ↵
    1. Janušonis S
    (2014) Serotonin dynamics in and around the central nervous system: Is autism solvable without fundamental insights? Int J Dev Neurosci 39:9–15.
    OpenUrl
  36. ↵
    1. Prafullata S,
    2. Bhakare PS,
    3. Vinchurkar A
    (2016) Study of serotonin level in autism. Indian Journal of Basic and Applied Medical Research 5:550–553.
    OpenUrl
  37. ↵
    1. Gottfried C,
    2. Bambini-Junior V,
    3. Francis F,
    4. Riesgo R,
    5. Savino W
    (2015) The Impact of Neuroimmune Alterations in Autism Spectrum Disorder. Front Psychiatry 6:121.
    OpenUrlPubMed
  38. ↵
    1. Margolis KG,
    2. Li Z,
    3. Stevanovic K,
    4. Saurman V,
    5. Israelyan N,
    6. Anderson GM,
    7. et al.
    (2016) Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function. J Clin Invest 126:2221–2235.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Veenstra-VanderWeele J,
    2. et al.
    (2012) Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc Natl Acad Sci U S A 109:5469–5474.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section